lilly glp-1 injection Novo, buoyed by fast-growing drug sales Eli Lilly launches weight-loss drug
Description
Last week, Metsera unveiled early Phase IIa data for MET-097i, touting 11.3% weight loss after 12 weeks, which reached as high as 20% in some patients
Off J Am Coll Gastroenterol|ACG 96(12):33233328 Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA et al (2008) Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial
Amylin-induced downregulation of hippocampal neurogenesis is attenuated by leptin in a STAT3/AMPK/ERK-dependent manner in mice
10.1038/nrendo.2017.151 43 ZinmanB.WannerC.LachinJ
